| 0.8 |
6.1 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.6 |
1.8 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.4 |
0.8 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.3 |
1.0 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.3 |
0.6 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.3 |
0.6 |
GO:1905065 |
positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.3 |
0.6 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.3 |
3.5 |
GO:0097067 |
negative regulation of erythrocyte differentiation(GO:0045647) cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 |
1.0 |
GO:0050904 |
diapedesis(GO:0050904) |
| 0.2 |
0.9 |
GO:0098763 |
mitotic cell cycle phase(GO:0098763) |
| 0.2 |
0.6 |
GO:0050929 |
corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.2 |
0.8 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.2 |
0.7 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 |
0.9 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.2 |
0.7 |
GO:0021856 |
cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
| 0.2 |
0.5 |
GO:1902336 |
neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
| 0.1 |
1.6 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
1.8 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.1 |
0.6 |
GO:1900085 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) |
| 0.1 |
1.0 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.1 |
0.3 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.1 |
0.4 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.1 |
0.2 |
GO:0045014 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) detection of glucose(GO:0051594) |
| 0.1 |
0.8 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.1 |
0.3 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 |
0.2 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.1 |
2.4 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
0.2 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.1 |
0.6 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 |
0.9 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.0 |
0.6 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.0 |
0.3 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.0 |
0.8 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.3 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 |
3.5 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 |
0.3 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
0.1 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.0 |
0.1 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.0 |
0.3 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.0 |
0.3 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) positive regulation of interleukin-10 production(GO:0032733) |
| 0.0 |
0.1 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.0 |
0.3 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.0 |
1.5 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.0 |
0.6 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.1 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.4 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.0 |
0.3 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
